<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39074096</PMID><DateCompleted><Year>2024</Year><Month>07</Month><Day>29</Day></DateCompleted><DateRevised><Year>2024</Year><Month>07</Month><Day>31</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>19</Volume><Issue>7</Issue><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS One</ISOAbbreviation></Journal><ArticleTitle>The association between prolonged SARS-CoV-2 symptoms and work outcomes.</ArticleTitle><Pagination><StartPage>e0300947</StartPage><MedlinePgn>e0300947</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e0300947</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0300947</ELocationID><Abstract><AbstractText>While the early effects of the COVID-19 pandemic on the United States labor market are well-established, less is known about the long-term impact of SARS-CoV-2 infection and Long COVID on employment. To address this gap, we analyzed self-reported data from a prospective, national cohort study to estimate the effects of SARS-CoV-2 symptoms at three months post-infection on missed workdays and return to work. The analysis included 2,939 adults in the Innovative Support for Patients with SARS-CoV-2 Infections Registry (INSPIRE) study who tested positive for their initial SARS-CoV-2 infection at the time of enrollment, were employed before the pandemic, and completed a baseline and three-month electronic survey. At three months post-infection, 40.8% of participants reported at least one SARS-CoV-2 symptom and 9.6% of participants reported five or more SARS-CoV-2 symptoms. When asked about missed work due to their SARS-CoV-2 infection at three months, 7.2% of participants reported missing &#x2265;10 workdays and 13.9% of participants reported not returning to work since their infection. At three months, participants with &#x2265;5 symptoms had a higher adjusted odds ratio of missing &#x2265;10 workdays (2.96, 95% CI 1.81-4.83) and not returning to work (2.44, 95% CI 1.58-3.76) compared to those with no symptoms. Prolonged SARS-CoV-2 symptoms were common, affecting 4-in-10 participants at three-months post-infection, and were associated with increased odds of work loss, most pronounced among adults with &#x2265;5 symptoms at three months. Despite the end of the federal Public Health Emergency for COVID-19 and efforts to "return to normal", policymakers must consider the clinical and economic implications of the COVID-19 pandemic on people's employment status and work absenteeism, particularly as data characterizing the numerous health and well-being impacts of Long COVID continue to emerge. Improved understanding of risk factors for lost work time may guide efforts to support people in returning to work.</AbstractText><CopyrightInformation>Copyright: &#xa9; 2024 Venkatesh et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Venkatesh</LastName><ForeName>Arjun K</ForeName><Initials>AK</Initials><Identifier Source="ORCID">0000-0002-8248-0567</Identifier><AffiliationInfo><Affiliation>Department of Emergency Medicine, Yale School of Medicine, New Haven, Connecticut, United States of America.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Outcomes Research and Evaluation (CORE), Section of Cardiovascular Medicine, Yale School of Medicine, Connecticut, United State of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Huihui</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Center for Outcomes Research and Evaluation (CORE), Section of Cardiovascular Medicine, Yale School of Medicine, Connecticut, United State of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Malicki</LastName><ForeName>Caitlin</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine, Yale School of Medicine, New Haven, Connecticut, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gottlieb</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine, Rush University Medical Center, Chicago, Illinois, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Elmore</LastName><ForeName>Joann G</ForeName><Initials>JG</Initials><AffiliationInfo><Affiliation>Division of General Internal Medicine and Health Services Research, David Geffen School of Medicine at the University of California, Los Angeles (UCLA), Los Angeles, California, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hill</LastName><ForeName>Mandy J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine, UTHealth Houston, Houston, Texas, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Idris</LastName><ForeName>Ahamed H</ForeName><Initials>AH</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Montoy</LastName><ForeName>Juan Carlos C</ForeName><Initials>JCC</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine, University of California, San Francisco, San Francisco, California, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>O'Laughlin</LastName><ForeName>Kelli N</ForeName><Initials>KN</Initials><AffiliationInfo><Affiliation>Departments of Emergency Medicine and Global Health, University of Washington, Seattle, Washington, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rising</LastName><ForeName>Kristin L</ForeName><Initials>KL</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania, United States of America.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Connected Care, Thomas Jefferson University, Philadelphia, Pennsylvania, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stephens</LastName><ForeName>Kari A</ForeName><Initials>KA</Initials><AffiliationInfo><Affiliation>Department of Family Medicine, University of Washington, Seattle, Washington, United States of America.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Informatics and Medical Education, University of Washington, Seattle, Washington, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Spatz</LastName><ForeName>Erica S</ForeName><Initials>ES</Initials><AffiliationInfo><Affiliation>Department of Epidemiology, Yale School of Public Health, New Haven, Connecticut, United States of America.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Section of Cardiovascular Medicine, Yale School of Medicine, New Haven, Connecticut, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weinstein</LastName><ForeName>Robert A</ForeName><Initials>RA</Initials><Identifier Source="ORCID">0000-0002-3390-858X</Identifier><AffiliationInfo><Affiliation>Division of Infectious Diseases, Department of Internal Medicine, Rush University Medical Center, Chicago, Illinois, United States of America.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, Cook County Hospital, Chicago, Illinois, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>INSPIRE Group</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>07</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D062707" MajorTopicYN="N">Return to Work</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004651" MajorTopicYN="N">Employment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057566" MajorTopicYN="N">Self Report</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000041" MajorTopicYN="N">Absenteeism</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>I have read the journal&#x2019;s policy and the authors of this manuscript have the following competing interests: AHI receives research grant funding from the University of Texas Southwestern Medical Center outside of the submitted work. AKV receives grants from the Agency for Healthcare Research and Quality and the SAEM Foundation outside the submitted work. ESS receives grant funding from the National Heart, Lung, and Blood Institute (R01HL151240), and the Patient Centered Outcomes Research Institute (HM-2022C2-28354). JCCM receives research grant funding from SAMHSA (1H79TI084428-01 and 1H79TI085981-01, PI LeSaint), FDA (75F40122C00116, PI Anderson), NIH-NINDS (U24NS129501, PI Rodriguez) outside the submitted work. JE is Editor-in-chief of the Adult Primary Care topics at UpToDate. KLR receives research grant funding from Abbott Diagnostics, DermTech, MeMed, Prenosis, Siemens Healthcare Diagnostics, PROCOVAXED funded by NIAID 1R01AI166967, and PREVENT funded by CDC U01CK00048 outside the submitted work. KNO receives research grant funding for PROCOVAXED funded by NIAID R01 AI166967, PI: Rodriguez outside the submitted work. MG receives grant funding from the Biomedical Advanced Research and Development Authority Research Grant, the Bill and Melinda Gates Foundation, and the Society of Directors of Research in Medical Education Grant outside the submitted work. MJH receives research grant funding from an Investigator Award from Merck, MISP 100099, PI: Hill outside the submitted work. The following authors have declared that no competing interests exist: HY, KAS, RAW. This does not alter our adherence to PLOS ONE policies on sharing data and materials.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>4</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>7</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>7</Month><Day>29</Day><Hour>18</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>7</Month><Day>29</Day><Hour>18</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>7</Month><Day>29</Day><Hour>13</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>7</Month><Day>29</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39074096</ArticleId><ArticleId IdType="pmc">PMC11285965</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0300947</ArticleId><ArticleId IdType="pii">PONE-D-24-09134</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>The Labor Supply Rebound from the Pandemic. The White House.
2023. 
Apr
17. Available from: https://www.whitehouse.gov/cea/written-materials/2023/04/17/the-labor-supply-rebound-from-the-pandemic/.</Citation></Reference><Reference><Citation>Ramos M. Employment recovery continues in 2021, with some industries reaching or exceeding their prepandemic employment levels," Monthly Labor Review, U.S. Bureau of Labor Statistics, May 2022, 10.21916/mlr.2022.15.</Citation><ArticleIdList><ArticleId IdType="doi">10.21916/mlr.2022.15</ArticleId></ArticleIdList></Reference><Reference><Citation>Bairoliya N, Imrohoroglu A. Macroeconomic consequences of stay-at-home policies during the COVID-19 pandemic. Eur Econ Rev. 2023;152:104266. doi: 10.1016/j.euroecorev.2022.104266</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.euroecorev.2022.104266</ArticleId><ArticleId IdType="pmc">PMC9672847</ArticleId><ArticleId IdType="pubmed">36466082</ArticleId></ArticleIdList></Reference><Reference><Citation>B&#xe9;land, LP, Brodeur A, Wright, T. Covid-19, Stay-at-Home Orders and Employment: Evidence from CPS Data. IZA Discussion Paper No. 13282, Available at SSRN: https://ssrn.com/abstract=3608531 or 10.2139/ssrn.3608531.</Citation><ArticleIdList><ArticleId IdType="doi">10.2139/ssrn.3608531</ArticleId></ArticleIdList></Reference><Reference><Citation>Frontera JA, Yang D, Lewis A, Patel P, Medicherla C, Arena V, et al.. A prospective study of long-term outcomes among hospitalized COVID-19 patients with and without neurological complications. J Neurol Sci. 2021;426:117486. doi: 10.1016/j.jns.2021.117486</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2021.117486</ArticleId><ArticleId IdType="pmc">PMC8113108</ArticleId><ArticleId IdType="pubmed">34000678</ArticleId></ArticleIdList></Reference><Reference><Citation>Goda GS, Soltas EJ. The impacts of Covid-19 absences on workers. J Public Econ. 2023;222:104889. doi: 10.1016/j.jpubeco.2023.104889</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpubeco.2023.104889</ArticleId><ArticleId IdType="pmc">PMC10113603</ArticleId><ArticleId IdType="pubmed">37152805</ArticleId></ArticleIdList></Reference><Reference><Citation>Post-COVID Conditions: Information for Healthcare Providers. Centers for Disease Control and Prevention:
2023. 
Sep
11. Available from: https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-care/post-covid-conditions.html.</Citation></Reference><Reference><Citation>Post COVID-19 condition (Long COVID).
World Health Organization: 2022. 
Dec
7. Available from: https://www.who.int/europe/news-room/fact-sheets/item/post-covid-19-condition.</Citation></Reference><Reference><Citation>Nearly One in Five American Adults Who Have Had COVID-19 Still Have "Long COVID". Centers for Disease Control and Prevention; 2022. 
Jun
22. Available from: https://www.cdc.gov/nchs/pressroom/nchs_press_releases/2022/20220622.htm.</Citation></Reference><Reference><Citation>Ziauddeen N, Pantelic M, O&#x2019;Hara ME, Hastie C, Alwan NA. Impact of long COVID-19 on work: a co-produced survey. Lancet. 2023;402 Suppl 1:S98.</Citation><ArticleIdList><ArticleId IdType="pubmed">37997145</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, Assaf GS, McCorkell L, Wei H, Low RJ, Re&#x2019;em Y, et al.. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. 2021;38:101019. doi: 10.1016/j.eclinm.2021.101019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101019</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Shining a Light on Long COVID: An Analysis of Workers&#x2019; Compensation Data. The New York State Insurance Fund.
2023. 
Jan
24. Available from: https://ww3.nysif.com/-/media/Files/NYSIF_Publications/PDF/NYSIFLongCOVIDStudy2023.ashx.</Citation></Reference><Reference><Citation>O&#x2019;Laughlin KN, Thompson M, Hota B, Gottlieb M, Plumb ID, Chang AM, et al.. Study protocol for the Innovative Support for Patients with SARS-CoV-2 Infections Registry (INSPIRE): A longitudinal study of the medium and long-term sequelae of SARS-CoV-2 infection. PLoS One. 2022;17(3):e0264260. doi: 10.1371/journal.pone.0264260</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0264260</ArticleId><ArticleId IdType="pmc">PMC8893622</ArticleId><ArticleId IdType="pubmed">35239680</ArticleId></ArticleIdList></Reference><Reference><Citation>Gottlieb M, Wang RC, Yu H, Spatz ES, Montoy JCC, Rodriguez RM, et al.. Severe Fatigue and Persistent Symptoms at 3 Months Following Severe Acute Respiratory Syndrome Coronavirus 2 Infections During the Pre-Delta, Delta, and Omicron Time Periods: A Multicenter Prospective Cohort Study. Clin Infect Dis. 2023;76(11):1930&#x2013;41. doi: 10.1093/cid/ciad045</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciad045</ArticleId><ArticleId IdType="pmc">PMC10249989</ArticleId><ArticleId IdType="pubmed">36705268</ArticleId></ArticleIdList></Reference><Reference><Citation>Spatz ES, Gottlieb M, Wisk LE, Anderson J, Chang AM, Gentile NL, et al.. Three-Month Symptom Profiles Among Symptomatic Adults With Positive and Negative Severe Acute Respiratory Syndrome Coronavirus 2 Tests: A Prospective Cohort Study From the INSPIRE Group. Clin Infect Dis. 2023;76(9):1559&#x2013;66. doi: 10.1093/cid/ciac966</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciac966</ArticleId><ArticleId IdType="pmc">PMC11361781</ArticleId><ArticleId IdType="pubmed">36573005</ArticleId></ArticleIdList></Reference><Reference><Citation>Gottlieb M, Spatz ES, Yu H, Wisk LE, Elmore JG, Gentile NL, et al.. Long COVID Clinical Phenotypes up to 6 Months After Infection Identified by Latent Class Analysis of Self-Reported Symptoms. Open Forum Infect Dis. 2023;10(7):ofad277. doi: 10.1093/ofid/ofad277</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofad277</ArticleId><ArticleId IdType="pmc">PMC10327879</ArticleId><ArticleId IdType="pubmed">37426952</ArticleId></ArticleIdList></Reference><Reference><Citation>Montoy JCC, Ford J, Yu H, Gottlieb M, Morse D, Santangelo M, et al.. Prevalence of Symptoms &lt;/ = 12 Months After Acute Illness, by COVID-19 Testing Status Among Adults&#x2014;United States, December 2020-March 2023. MMWR Morb Mortal Wkly Rep. 2023;72(32):859&#x2013;65.oy.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10415002</ArticleId><ArticleId IdType="pubmed">37561663</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang RC, Gottlieb M, Montoy JCC, Rodriguez RM, Yu H, Spatz ES, et al.. Association Between SARS-CoV-2 Variants and Frequency of Acute Symptoms: Analysis of a Multi-institutional Prospective Cohort Study-December 20, 2020-June 20, 2022. Open Forum Infect Dis. 2023;10(7):ofad275. doi: 10.1093/ofid/ofad275</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofad275</ArticleId><ArticleId IdType="pmc">PMC10327880</ArticleId><ArticleId IdType="pubmed">37426947</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowe B, Xie Y, Al-Aly Z. Postacute sequelae of COVID-19 at 2 years. Nature Medicine. 2023;29(9):2347&#x2013;57. doi: 10.1038/s41591-023-02521-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-023-02521-2</ArticleId><ArticleId IdType="pmc">PMC10504070</ArticleId><ArticleId IdType="pubmed">37605079</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly Z. Diabetes after SARS-CoV-2 infection. The Lancet Diabetes &amp; Endocrinology. 2023;11(1):11&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9714974</ArticleId><ArticleId IdType="pubmed">36463908</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, Chinchilli VM, Ssentongo P, Ba DM. Association of Long COVID with mental health disorders: a retrospective cohort study using real-world data from the USA. BMJ Open. 2024;14(2):e079267. doi: 10.1136/bmjopen-2023-079267</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2023-079267</ArticleId><ArticleId IdType="pmc">PMC10840030</ArticleId><ArticleId IdType="pubmed">38309763</ArticleId></ArticleIdList></Reference><Reference><Citation>Ladlow P, Holdsworth DA, O&#x2019;Sullivan O, Barker-Davies RM, Houston A, Chamley R, et al.. Exercise tolerance, fatigue, mental health, and employment status at 5 and 12 months following COVID-19 illness in a physically trained population. J Appl Physiol (1985). 2023;134(3):622&#x2013;37. doi: 10.1152/japplphysiol.00370.2022</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/japplphysiol.00370.2022</ArticleId><ArticleId IdType="pmc">PMC10010915</ArticleId><ArticleId IdType="pubmed">36759161</ArticleId></ArticleIdList></Reference><Reference><Citation>Akinbami LJ, Kruszon-Moran D, Wang CY, Storandt RJ, Clark J, Riddles MK, et al.. SARS-CoV-2 Serology and Self-Reported Infection Among Adults&#x2014;National Health and Nutrition Examination Survey, United States, August 2021-May 2022. MMWR Morb Mortal Wkly Rep. 2022;71(48):1522&#x2013;5. doi: 10.15585/mmwr.mm7148a4</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7148a4</ArticleId><ArticleId IdType="pmc">PMC9721142</ArticleId><ArticleId IdType="pubmed">36454698</ArticleId></ArticleIdList></Reference><Reference><Citation>Kromydas T, Demou E, Edge R, Gittins M, Katikireddi SV, Pearce N, et al.. Occupational differences in the prevalence and severity of long-COVID: analysis of the Coronavirus (COVID-19) Infection Survey. Occupational and Environmental Medicine [Internet]. 2023. Oct 1;80(10):545&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7615205</ArticleId><ArticleId IdType="pubmed">37770179</ArticleId></ArticleIdList></Reference><Reference><Citation>Capasso A, Kim S, Ali SH, Jones AM, DiClemente RJ, Tozan Y. Employment conditions as barriers to the adoption of COVID-19 mitigation measures: how the COVID-19 pandemic may be deepening health disparities among low-income earners and essential workers in the United States. BMC Public Health. 2022;22(1):870. doi: 10.1186/s12889-022-13259-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12889-022-13259-w</ArticleId><ArticleId IdType="pmc">PMC9058755</ArticleId><ArticleId IdType="pubmed">35501740</ArticleId></ArticleIdList></Reference><Reference><Citation>Abel J, Deitz R. Some Workers Have Been Hit Much Harder than Others by the Pandemic.
Liberty Street Economics. 2021. 
Feb
9. Available from: https://libertystreeteconomics.newyorkfed.org/2021/02/some-workers-have-been-hit-much-harder-than-others-by-the-pandemic.html.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>